Last reviewed · How we verify

NCT04708392

Stimulation Change Effects on Quantitative Sensory Testing in Neuromodulation Patients

Completed NA Last updated 15 January 2021
What this trial tests

NA trial testing Spinal Cord Stimulator in Chronic Pain in 16 participants. Completed in 11 September 2018.

Timeline
29 July 2017
Primary endpoint
31 July 2018
11 September 2018

Quick facts

Lead sponsorAlbany Medical College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment16
Start date29 July 2017
Primary completion31 July 2018
Estimated completion11 September 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Albany Medical College

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to evaluate the effectiveness of two types of spinal cord stimulation programming types, in comparison to each other as well as patient baseline data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Spinal Cord Stimulator

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Albany Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04708392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing